THERAPEUTIC POTENTIAL OF THRIPHALA RASAYANA IN PRIMARY HYPERLIPIDEMIA- AN EXPERIMENTAL COMPARATIVE STUDY by Mini V G Vettikkottil George & Subhash Babu N
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
     IJAPR | May 2020 | Vol 8 | Issue 5  13 
International Journal of Ayurveda  
and Pharma Research 
 
Research Article 
 
THERAPEUTIC POTENTIAL OF THRIPHALA RASAYANA IN PRIMARY HYPERLIPIDEMIA- AN 
EXPERIMENTAL COMPARATIVE STUDY  
Mini V G1*, Subhash Babu N2 
*1Associate Professor, 2Former Professor and HOD, Dept. of Kayachikitsa, Govt Ayurveda College, 
Thiruvananthapuram, Kerala, India.  
ABSTRACT 
Background: Elevated concentration of lipids in the blood is considered as the well-established and 
strong risk factor for cardiovascular disease. Primary hyperlipidaemia occurs solely due to 
interaction of mutated gene with unprecedented epidemiologic transitions associated with lifestyle 
changes and dietary patterns. Early detection and management of asymptomatic hyperlipidaemia is 
imperative to reduce the incidence of cerebrovascular, peripheral vascular and coronary artery 
diseases. Preferred screening test i.e. lipid panel test will be substantial on many levels including 
mortality, morbidity and staggering financial burden related with vascular endothelial dysfunction 
and atherosclerotic changes. Simple, low-cost and potential pharmacological interventions with 
Ayurveda drugs are highly beneficial in these preventable epidemics. The main ingredient, 
“Thriphala“ in the trial drug is considered as the best known rejuvenative (Rasayana) combination, 
which stimulate and correct the impaired inherent digestive capacity (Dhatwagni) by removing the 
inflammatory and obstructive causes (Srothorodha) associated with the dysfunctions in lipid 
metabolism. Objective: This study aims to evaluate the effect of an Ayurveda formulation on lipid 
level in patients with primary Hyperlipidaemia. It also ascertains the safety of the therapeutic 
formulation by evaluating the variations in the blood biochemical parameters. Methods: The study 
design was an experimental comparative study intended to compare the effect of potentiated 
Thriphala rasayana with standard anti-lipidemic drug in primary hyperlipidaemia. 29 cases in study 
group and 15 samples in control group participated in the trial. The data was analysed by using 
appropriate statistical techniques. Results: In the study group the values of total cholesterol, LDL and 
Atherogenic index shows more significant result than the control group receiving conventional anti-
lipidemic drug. Conclusion: strategies for early detection and comprehensive management with 
Ayurveda formulations can be highly effective in reducing the global burden of vascular dysfunction 
related with hyperlipidaemia. 
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INTRODUCTION 
The prevalence of cardiovascular disease 
(CVD) continues to increase globally. CVDs generally 
refers to complex pathophysiological conditions that 
alter the total cross sectional area of blood vessels 
and opposes the blood flow particularly in systemic 
circulation[1]. Abnormal blood concentrations of 
lipids are closely interconnected in the pathogenesis 
of CVD. Hyperlipidaemia is a major metabolic 
disorder, contributing substantially to the 
development and clinical expressions of vascular 
abnormalities. [2] Disorders of lipid metabolism are 
increasingly prevalent in this era due to the 
interaction of mutated inherited factors with changes 
in lifestyle, unbalanced food habits and stressful 
mental conditions. Vascular endothelium is 
considered as an interface between blood stream and 
vessel wall, actively involved in homoeostasis [3]. Any 
variation in the functional ability of this interface is 
believed to be primary importance in the 
pathogenesis of disease related with circulatory 
system. Endothelial dysfunction is an early indicator 
of chronic inflammatory process i.e. atherosclerosis 
and other life threatening complications [4]. Free 
radical scavenging and neutralising effects of 
Antioxidants help to maintain the physiological redox 
balance, gets depleted in chronic conditions like 
hyperlipidaemia. Abnormalities in lipid metabolism 
disrupt the normal biochemical balance required for 
cardiovascular performance and create accelerated 
atherogenic events. Direct effect of impaired lipid 
metabolism in turn leads to myocardial dysfunction, 
reperfusion injury and decrease stress adaption. In 
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these circumstances interventions with natural 
antioxidant supplements may play a key role in 
normalizing altered lipid metabolism and preventing 
unwanted oxidative reactions. Therefore an early 
detection of cases with positive family history and 
management with Ayurveda formulations definitely 
have a reiterated role in preventing deleterious 
consequences of vascular injury and subsequent 
myocardial oxidative stress associated with 
Hyperlipidaemia. 
In Ayurveda perspective, lipid components in 
the body can be treated as derivative of fat tissue 
(Medho dhatu). While analysing the Kapha bhava in 
Hyperlipidaemia cases, it is observed that its qualities 
are similar to Bahu drava stage. Chakrapani 
comments that the Bahu drava condition of Kapha 
itself causes Bahuabadhata of Medo dhatu[5]. 
According to the basic concepts, lipid tissue and 
Kapha dosha are mutually inter related having similar 
basic properties. The etiological factors responsible 
for all metabolic syndromes such as Diabetes 
mellitus, obesity, and other disorders related with 
over nourishment are similar to that of Kapha dosha 
and lipid tissue vitiation [6]. In Hyperlipidaemia, the 
inherent low level digestive capacity leads to the 
formation of toxic substances called Ama in the 
body[7]. Impaired tissue formation and toxic products 
from metabolic error can hamper tissue formation 
along with the vitiation of blood. These pathological 
processes in turn leads to obstruction and vitiation of 
channels. Similar process can be observed in 
Hyperlipidaemia, also closely inter connected to life 
limiting conditions. Drugs and combinations having 
Rasayana properties particularly Thriphala rasayana 
definitely has potential benefits over this impaired 
lipid metabolism. 
MATERIALS AND METHODS 
Study design: An experimental comparative study – 
The trial drug “Thriphala choorna” potentiated with 
decoction made of Khadira and Asana administered 
to the study group, its effect was compared and 
statistically analysed with the control group receiving 
standard anti-lipidamic drug (statin). 
Study setting: Adequate sample size diagnosed with 
primary hyperlipidaemia was consecutively allocated 
from the outpatient department of Kayachikitsa, 
Govt. Ayurveda College Hospital, 
Thiruvananthapuram.  
Inclusion criteria: Both male and female cases in the 
age group of 20-60 years identified with primary 
Hyperlipidaemia.  
Exclusion criteria: Acquired causes of secondary 
Hyperlipidaemia such as Diabetes mellitus, thyroid 
dysfunction, and nephrotic syndrome, chronic liver 
and renal failure are excluded from the study. 
Possibilities of oral medications including 
contraceptive pills and hormone therapies 
potentially affect lipid metabolism are also excluded 
from the trial. 
Procedure: Hyperlipidaemia in most of the cases are 
asymptomatic and assigned as the leading risk factor 
associated with cardiovascular disease. Preliminary 
data was collected by using fasting lipid profile test. A 
well-structured clinical research proforma was set up 
for the data collected from the history taking, initial 
screening tests and cardiovascular system 
examination. 
As per the inclusion and exclusion criteria 
samples were consecutively allocated in to the study 
and control group till attaining the sample size of 
total 44 patients. Base line data collection and 
laboratory investigations were done before and after 
intervention with the trial drug. Both male and 
female cases in the age limit of 20-60 from the study 
setting were selected for the study. They were 
subjected to detailed general and systemic 
examination and investigations including complete 
blood count, fasting lipid profile, liver function tests, 
renal function tests and other relevant biochemical 
assessment to exclude secondary hyperlipidaemia 
were done at the clinical lab settings in the Govt. 
Ayurveda College Hospital, Thiruvananthapuram. 
The trial drug was administered to the samples 
confined to the study group in capsule form. Two 
capsules of the trial drug, with Anupana of lukewarm 
water were given thrice a day after food for one 
month, whereas standard lipid lowering therapy with 
statin was strictly followed in the control group. All 
cases in both the groups were advised to follow 
dietary regimen suitable for hyperlipidaemia. After 
the trial of one month duration the response to the 
treatment was assessed. The collected data obtained 
before and after the study was subjected to statistical 
analysis using appropriate statistical techniques. In 
order to find out the effectiveness of both modern 
and Ayurveda management before and after the trial, 
paired t test was computed. For comparing the 
effectiveness between the trial and control groups, 
student t test was performed. 
Drug review: The trial drug in the present study is a 
therapeutic formulation mentioned in chapter on 
Sthoulya (obesity) treatment of Chikitsamanjari[8], an 
Ayurveda text which explicitly details the traditional 
keralite management for general diseases. The 
formula consists of Thriphala a well-recognized and 
highly efficacious poly herbal Rasayana combination 
consisting of fruit rind of the plant species Emblica 
officianalis, (Amalaki), Terminalia bellerica 
(Vibhitaki) and Terminalia chebula (Haritaki) 
potentiated in the concentrated decoction of Khadira 
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(Acacia catechu) and Asana (Pterocarpus marsupium) 
by a process called Bhavana (potentiation) which 
helps to impart the properties of Khadira and Asana 
in to the Thriphala. While analysing the 
aetiopathogenesis of primary hyperlipidemia, it is 
evident that there is an inherent inactivity of 
digestive fire and accumulation of toxic products in 
the form of vitiated Kapha, Medas having qualitative 
changes. Thriphala is considered as the best drug 
with enormous rejuvenating capacity can reverse the 
metabolic errors by its specific action on Kleda, 
Medas and Kapha (Soshana properties). 
Experimentally all these drugs have proven anti- 
liipidemic and anti-oxidant properties[9]. The 
therapeutic properties of Haritaki is specifically 
indicated in inflammatory process i.e. atherosclerosis 
due to lipid accumulation and the resulting vascular 
abnormalities (Dhamani pratichayam)[10].  
RESULTS 
Interpretation of data related to demographic 
and socio- economic background 
Age: majority of the patients belonged to the age 
group 40-49 (55.2%) 
Sex: females constituted 58.6% in the study group 
and 66.7% in the control group  
Religion: maximum number of patients in the study 
group (69%) and in the control group (86.7%) 
belonged to Hindu community. 17.2% in the study 
group and 6.7% in the control group belonged to 
Muslim community and the remaining in both groups 
from Christian community.  
Educational status: majority of patients in both 
groups were having higher level of education. 20.7% 
in the study group and 26.7% in the control group 
were educated below matriculation, whereas 6.9% in 
the study group and 6.7% in the control group were 
uneducated. 
Domicile: 93.1% of samples in the study group 
belonged to rural population and the remaining 
belonged to urban population. 80% of control group 
belonged to rural population. The immense burden of 
most of the non-communicable disease including 
metabolic disease in rural area may be due to lack of 
awareness in healthy life style and diet patterns. 
Socio economic status: 75.9% in study group and 
46.75 in the control group were from middle class 
family. 6.9% in the study group and 20% in the 
control group were in the poor class and remaining 
belonged to affluent economic status. 
Occupation: House makers constitute 44.8% in the 
study group and 66.7% in the control group. 34.5% in 
the study group and 26.7% in the control group were 
employees leading with sedentary work life and 
heading serious work place health issues. Manual 
workers constitute 20.7% in the study group and 
6.7% in the control group. 
Interpretation of data related to life style 
behaviours 
Diet: Majority of patients 82.8% in the study group 
and 93.3% in the control group were following non 
vegetarian diet. 
Sleep: Sleep pattern shows that most of the cases in 
both groups had sound sleep and day sleeping was 
not practiced by all in this study 
Exercise: All the patients were doing mild to 
moderate activity occasionally; nobody was 
practicing regular exercise. 
Family history: In the study group 51.7% and in the 
control group 53.3% had a positive family history of 
hyperlipidaemia.  
Interpretation of data related to hyperlipidaemia 
Primary Hyperlipidaemia is mainly due to the 
interaction of genetic causes with unhealthy lifestyle 
habits and dietary patterns. Among the various 
etiological; factors described in Ayurveda classics, 
Beeja dushti is an inevitable factor. su.soo.15/34. 
Patients having VataKapha constitution tend to 
predominate in hyperlipidaemia affecting 63% in the 
study group and 72% in the control group, indicates 
that Vathakapha prakrithi persons are more prone to 
dysfunction in lipid metabolism.  
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Interpretation of data related to response of treatment effect of treatment on total cholesterol level in 
the study group mean value of total cholesterol was reduced from 250 to 228.5 after treatment. The P value 
shows statistically significant change at 0.1% level, whereas in the control group the mean value of total 
cholesterol was reduced from 258.7 to 229.3 after the study, showing significance at 5% level. 
Effect of treatment on LDL 
 
In the control group the mean value of LDL was 175.1 which came down to 143.7 after treatment showing a 
significance at 1% level. In the study group the mean value of LDL was reduced from 175.3 to 152.4 after 
treatment show a significant 0.1% level. 
Table 1: Effect of treatment on HDL  
Group Stage Mean SD Paired t  P 
Study BT 43.3 13.3 0.9 P<0.05 
AT 45.2 12.2 
Control BT 44.3 9.8 1.41 P<0.05 
AT 48.7 9.0 
Regarding HDL the mean value of 44.3 in the control group and 43.3 in the study group was increased to 48.7 
and 45.2 respectively after the treatment. But these marginal changes were found to be not statistically 
significant. 
Table 2: Effect of treatment on TGL 
Group Stage Mean SD Paired t P 
Study BT 156.9 43.1 0.4 P<0.05 
AT 154.4 49.8 
Control BT 196.1 63.4 1.1 P<0.05 
AT 184.6 55.8 
In the control group the mean value of Triglyceride after treatment showed a decrease in the average value 
from 196.1 to 184.6, whereas in the study group the mean value was reduced from 156.9 to 154.4. The changes 
obtained in both groups were not found statistically significant (P>0.05). 
Effect of treatment on atherogenic index and HDL ratio 
 
Table 3: Effect of treatment on atherogenic index 
Group Stage Mean SD Paired t P 
Study BT 5.2 1.7 2.63 P<0.05 
AT 4.4 1.6 
Control  BT 5 1.1 3.47 P<0.01 
AT 3.8 1.1 
 
Table 4: Effect of treatment on HDL ratio 
Group Stage Mean SD Paired T P 
Study BT 0.2 0.1 1.87 P<0.05 
AT 0.3 0.1 
Control BT 0.2 0.0 3.21 P<0.01 
AT 0.3 0.1 
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Regarding atherogenic index and HDL ratio, it 
was found in the control group that a pre therapy 
mean value of 5 and 0.2 respectively was reduced to 
3.8 and raised to 0.3 respectively. On statistical 
analysis these changes were found to be statistically 
significant (P<0.01). In the study group, regarding 
Atherogenic index and HDL ratio after treatment the 
mean value of 5.2 and 0.2 become 4.4 and 0.3 
respectively. The changes in the Atherogenic index 
were found to be statistically significant (P<0.05) but 
changes in the HDL ratio was found to be statistically 
not significant. 
DISCUSSION 
Abnormalities related with the synthesis of 
endogenous substances from vascular endothelium 
and alterations in vascular biology are identified as 
an important biomarker for cardiovascular diseases. 
The development and progression of atherosclerosis 
and resulting perfusion injuries are mainly due to 
metabolic dysfunctions. 
The Indian traditional system of medicine, 
Ayurveda has rich source of concepts and potential 
therapeutic strategies available for the correction of 
these physiological alterations related with lipid 
metabolism. According to the concepts and basic 
principles of Ayurveda, normal digestive capacity of 
the body i.e., “Agni” play an important role in 
digestion and metabolism of the body. So any 
abnormality in the structural and functional 
mechanism facilitate digestive capacity (Agni) will 
disrupt the ability of the tissues to perform essential 
biochemical reactions including metabolism and 
transport of lipids. In primary hyperlipidaemia, 
interference of lipid metabolism is attributed to the 
interaction of mutated gene with unhealthy life style 
habits and dietary patterns. As per the basic concepts 
of Ayurveda, there is always an inherent reduced 
digestive capacity (diminished Jataragni and 
Dhattwagni) associated with patients having 
hampered lipid metabolism. Nutrient and tissue part 
Rasa dhatu formed during improper digestion are 
unable to perform the normal functions and are 
unable to transform subsequent tissues, partilcularly 
the Medho dhatu. As per Ashtangahrudaya, chapter 
on knowledge of Dosha (Doshadivijnaneeyam) 
specific function are assigned to different tissues of 
the body. Functions like nourishment (Preenana) for 
Rasa dhatu, lubrication or unctuousness (Snehana) 
for Medhodhatu (lipid tissue) etc. Any derangement 
in normal metabolism these functions and qualities of 
formed tissues become in a pathological condition. 
Thus unhealthy life style and unwholesome dietary 
habits along with inborn metabolic error is actively 
involved in aetio-pathogenesis of primary 
hyperlipidaemia. 
There is an extensive research data available 
to prove the free radical scavenging property and 
inhibitory effects of Thriphala powder on lipid 
peroxide formation. Polyphenols in Triphala powder 
possess anti-mutagenic activity. Flavonoids present 
in the combination particularly in Emblica possess 
diverse anti-oxidant and cardio protective action. It 
also effectively inhibits hepatic HMG-COA reductase 
activity and reduces the lipid levels. Tannoids of 
Emblica are potent inhibitors of aldosereductase is 
effective in the prevention and management of 
secondary complications. Catechin a bioflavonoid is 
actively present in Acacia catechu possesses 
antioxidant property and protects heart from 
oxidative damage. Pterosupin and liquitrigenin 
present in Pterocarpus mausupium identified as 
having the property of reducing total cholesterol, LDL 
and Atherogenic index. 
 Therapeutic Formulations especially 
Rasayana prayogas, having direct effect on digestive 
functions (i.e., Agni deepana and Ama pachana) and 
Medho dhatu (lipid tissues) are beneficial in the 
prevention and management of secondary 
complications like cardiovascular disease. Thriphala 
powder is considered as the best drug having 
Rasayana (anti-oxidant) property. Due to the Kleda, 
Meda, Kapha soshana and Lekhana properties it 
reduces the Bahudrava nature of Kapha dosha takes 
part in the pathogenesis of metabolic disorder. It is 
evident that vitiated digestive capacity actively 
involved in the disease pathology. The trial drug 
possesses Deepana (improving the functioning of 
digestive capacity) and Pachana i.e. detoxifying the 
impure toxic products produced as a result of excess 
lipid accumulation in the body (lipotoxicity). 
According to Charaka samhita “Vibhitaki” (Terminalia 
bellerica) specifically indicated in lipid abnormalities 
(Medhovikara). Sodalanighandu, describes the 
Medhohara property of Acacia catechu (Khadira). 
With all these references and scientifically proven 
properties, an ingredient present in the trial drug 
was effective in the management and prevention of 
complications in hyperlipidaemia.  
CONCLUSION 
The main conclusions derived from the study 
are potentiated Thriphala rasayana can lower the 
total cholesterol and LDL level at a more significant 
level when compared to the control group. Regarding 
atherogenic index and HDL ratio, the changes in 
atherogenic index were found to be statistically 
significant, whereas the changes and results 
observed in HDL, Triglyceride and HDL ratio were 
not statistically significant. Reports of renal and liver 
function tests before and after the trial proved that 
the trial drug produced no toxic effects on normal 
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physiology. Since primary hyperlipidaemia is an 
inherent defect, long term therapy is required to 
reverse the pathology. With this short period of 
assessment and limited sample size, we cannot draw 
a final conclusion about the long term potential 
benefits of Thriphala rasayana. Early diagnosis and 
judicial use of treatment strategies described in 
Ayurveda formulations can prevent secondary 
complications related with cardiovascular system. 
Treatment with drugs having antioxidant and free 
radical scavenging properties (Rasayana prayogas) 
explained in Ayurveda classics are highly beneficial in 
the management of non- communicable diseases. 
Particular care should be taken to prevent the 
harmful complications of metabolic error and 
vascular remodelling by educating the population 
about the necessity of early detection and proper 
managements.  
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